Shortcut menu


Contents Area

Scientific Program

ASGO 2019
"Optimal Gynecologic Cancer Care in Asia"

*Program is subject to change.

Daily Program
Time Program Speaker
[Special Session 3] International Research Collaboration through GCIG (90 min) Chair: Kazunori Ochiai (Japan)
Co-chair: Jae-Weon Kim (Korea)
08:30-08:45 Role of GCIG on changing the practice in gynecologic cancer patients Keiichi Fujiwara (Japan)
08:45-09:00 Operation and harmonization for international clinical trial management Yusuke Kajimoto (Japan)
09:00-09:15 Cervix & CCRN Sang-Young Ryu (Korea)
09:15-09:30 Ovarian cancer Rongyu Zang(China)
09:30-09:45 Endometrial cancer Jae-Weon Kim (Korea)
09:45-10:00 Discussion
[Oral 5] TR & Hereditary (90 min) Chair: Efren Domingo
(Philippines)
Co-chair: Dae-Hoon Jeong
(Korea)
08:30-08:40 Development and preclinical testing of patient-derived xenograft(PDX) models for uterine cancer Soo Young Jeong (Korea)
08:40-08:50 LncRNA RP11-395G23.3, as a competitive endogenous RNA, regulate PTEN expression by sponging miR-205-5p in the progression of endometrial cancer Weijuan Xin (China)
08:50-09:00 Calcium channel CAV1.3 participates in epithelial-mesenchymal transition of endometrial cancer cells induced by transforming growth factor β Yibo Dai (China)
09:00-09:10 Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers Jeong-Won Lee (Korea)
09:10-09:20 Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions Xuan Zong (China)
09:20-09:30 Clinicopathologic significance of mismatch repair protein expression in endometrial cancer Mi-Kyung Kim (Korea)
09:30-09:40 Long term outcome of young patients with mismatch-repair deficient endometrial carcinoma Mandy Man Yee Chu (Hong Kong)
09:40-09:50 Mutation landscape of germline and somatic BRCA1/2 genes in high-grade serous ovarian cancer patients Kyung Jin Eoh (Korea)
09:50-10:00 Hormone replacement therapy after premature surgical menopause and health services utilization Ji-Hyun Jang (Canada)
[Poster Discussion] (20 min)
08:30-08:50 Selected poster discussion: merits and demerits Yoo-Young Lee (Korea)
[Education Session 5] Uterine and Cervical Cancer Surgery (60 min) Chair: Ju Won Roh (Korea)
Co-Chair: Joong Sub Choi (Korea)
09:00-09:15 Radical hysterectomy Dae-Yeon Kim (Korea)
09:15-09:30 LEER Hee-Seung Kim (Korea)
09:30-09:45 TMMR for cervical cancer Rainer Kimmig (Germany)
09:45-10:00 PMMR for endometrial cancer Rainer Kimmig (Germany)
[Special Session 4] Clinical trial in Asia: Can We Make a Quantum Jump? (45 min) Chair: Wen Yee Chay (Singapore)
Co-chair: Jae-Hoon Kim (Korea)
10:20-10:35 Overview of the current status of clinical trials in Asia Kosei Hasegawa (Japan)
10:35-11:05 Discussion
[Oral 6] Cervical Cancer & GTN Treatment (70 min) Chair: Sang Hoon Kwon (Korea)
Co-chair: Dong Choon Park (Korea)
10:20-10:30 Ovarian metastasis in early-stage cervical cancer: a large single institution study Kittipat Charoenkwan (Thailand)
10:30-10:40 Impact of learning curve on the survival of abdominal or minimally invasive radical hysterectomy for early stage cervical cancer Hwajung Lee (Korea)
10:40-10:50 Impact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy with pelvic node dissection Kittinun Leetanaporn (Thailand)
10:50-11:00 Post-irradiation PD-L1 expression predicts better prognosis after carbon ion radiotherapy in uterine cervical adenocarcinoma Moito Iijima (Japan)
11:00-11:10 Comparisons of radiotherapy outcomes in cervical squamous cell carcinoma stage IIIB with and without lymph node enlargement Fitriyadi Kusuma (Indonesia)
11:10-11:20 Clinical significance of centralized surveillance of hydatidiform mole: five years' experience from a regional hospital in China Lan-zhou Jiao (China)
11:20-11:30 Gestational trophoblastic neoplasia: determinants of outcome Seema Singhal (India)
[Film 1A] (45 min) Chair: Xiaohua Wu (China)
Co-chair: Keun Ho Lee (Korea)
10:20-10:29 Nerve sparing modified laparoscopic radical hysterectomy with vaginal cuff closure and without uterine manipulator Huaiwu Lu (China)
10:29-10:38 Clinical anatomy required in identifying pelvic autonomic nerve system Yasuhiko Shiki (Japan)
10:38-10:47 Single-port laparoscopic radical trachelectomy with fluorescent image-guided sentinel lymph node dissection Sang Wun Kim (Korea)
10:47-10:56 Robotic single-port surgical staging for endometrial cancer using da Vinci SP® surgical system Jung Hun Lee (Korea)
10:56-11:05 Laparoscopic primary repair of duodenal perforation after laparoscopic para-aortic lymphadenectomy Hyeon Myeong Hong (Korea)
[Film 1B] (45 min) Chair: Andri Andrijono (Indonesia)
Co-chair: : Noh-Hyun Park (Korea)
11:05-11:14 Cervical cancer surgery Zhengmao Zhang (China)
11:14-11:23 Laparoscopic extraperitoneal systematic pelvic and PARA-aortic lymphadenectomy Supachai Raungkaewmanee (Thailand)
11:23-11:32 Laparoscopic extraperitoneal systematic pelvic and PARA-aortic lymphadenectomy Dae-yeon Kim (Korea)
11:32-11:41 Single-site robotic staging surgery for early stage ovarian cancer Ji Geun Yoo (Korea)
11:41-11:50 Combined technique of single-site robot and laparoscopy in comprehensive staging operation of endometrial cancer Bo-Ra Lee (Korea)
[Education Session 6] Training Session for Young Investigator and Research Nurse (50 min) Chair: Rongyu Zang (China)
Co-chair: Byoung-Gie Kim (Korea)
11:10-11:25 The Role of the CRC in an investigator initiated trial Ju Yeon Yi (Korea)
11:25-11:40 The role and environment of research nurse Noriko Fujiwara (Japan)
11:40-11:55 How to start investigator-initiated study? Jung-Yun Lee (Korea)
11:55-12:00 Discussion
[Special Symposium 3] (20 min) Chair: Sunghoon Kim (Korea)
12:10-12:30 New PARP inhibitor in recurrent ovarian cancer, regardless of BRCA status: the role of niraparib Aikou Okamoto (Japan)
[Symposium 7] Fertility Preservation Upfront (60 min) Chair: Jihong Liu (China)
Co-chair: Kimio Ushijima (Japan)
13:00-13:15 Radical trachelectomy for young patients with early cervical cancer: the past and the future Jin Li (China)
13:15-13:30 Fertility preserving treatment of early stage endometrial cancer  Xiaojun Chen (China)
13:30-13:45 Fertility preservation in early stage epithelial ovarian cancer  Hiroaki Kajiyama (Japan)
13:45-14:00 Fertility preservation for female cancer patients Yutaka Osuga (Japan)
[Education Session 7] Imaging in Ovarian Cancer Practice (60 min) Chair: Jae Hong No (Korea)
Co-chair: Seung-Su Han (Korea)
13:00-13:15 Imaging study before cytoreductive surgery Byung Kwan Park (Korea)
13:15-13:30 Imaging follow up strategy of ovarian cancer Jeong Yeon Cho (Korea)
13:30-13:45 Functional Imaging of ovarian cancer Dae Chul Jung (Korea)
13:45-14:00 Response evaluation: RECIST & iRECIST on imaging Sung Yoon Park (Korea)
[Special Session 5] From Good Research to Good Publication (60 min) Chair: Ki Hyung Kim (Korea)
Co-chair: Chunling Chen (China)
13:00-13:20 Ethical review of the research project Yawana Tanapat (Thailand)
13:20-13:40 Tips for success as a clinical investigator Soyi Lim (Korea)
13:40-14:00 Transparency in medical writing Seung-Hyuk Shim (Korea)
[Symposium 8] Chemotherapy and Related Supportive Care (60 min) Chair: Suresh Kumarasamy (Malaysia)
Co-chair: Taejin Kim (Korea)
14:05-14:20 Post chemotherapy quality of life in developing country Hariyono Winarto (Indonesia)
14:20-14:35 Hypersensitivity reactions to carboplatin and paclitaxel:
management and oncologic outcomes
Suwanit Therasakvichya (Thailand)
14:35-14:50 Hospice care by specialist palliative care team Yoon Jung Chang (Korea)
14:50-15:05 Pain control in patients with advanced stage cancer Seyoung Seo (Korea)
[Oral 7] Medical Treatment in Ovarian Cancer (60 min) Chair: Yong Jung Song (Korea)
Co-chair: Kwang-Beom Lee (Korea)
14:05-14:15 Bevacizumab maintenance therapy extended the overall survival for the histopathological mesenchymal transition type of high-grade serous ovarian carcinoma Kentaro Ishida (Japan)
14:15-14:25 Additional chemotherapy in epithelial ovarian cancer with residual disease after six cycles of postoperative adjuvant chemotherapy Se Ik Kim (Korea)
14:25-14:35 Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer Wei-Chun Chen (Taiwan)
14:35-14:45 Enhanced chemotherapy effects on gynecological cancers by using the combination of lipid bubble and ultrasound Kohei Yamaguchi (Japan)
14:45-14:55 Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising drug delivery system for ovarian cancer Hyeji Jeon (Korea)
14:55-15:05 The influence of depression on health utility value in patients with gynecologic cancer: a comparison with physical symptoms and performance status Hyemin Yeo (Korea)
[Education Session 8] Ovarian Cancer Surgery (60 min) Chair: Chi-Heum Cho (Korea)
Co-chair: Chih-Ming Ho (Taiwan)
14:05-14:20 Surgical technique : radical upper abdominal dissection/ resection Suk-Joon Chang (Korea)
14:20-14:35 Surgical technique : radical pelvic dissection/ resection Kazuyoshi Kato (Japan)
14:35-14:50 MSKCC resectability score and selection criteria for primary debulking surgery Dennis Chi (USA)
14:50-15:05 Role of lymphadenectomy in ovarian cancer Jianqing Zhu (China)
15:05-15:20 Closing Ceremony


Site Information & Copyright Area